Year |
Cultivar |
Treatment |
Proline (μg g−1FW) |
GABA (μg g−1FW) |
PDH activity (U L−1FW) |
BADH activity (U L−1FW) |
2018 |
Meixiangzhan-2 |
|
|
CK |
43.14 ± 1.37a |
32.19 ± 1.52a |
13.45 ± 0.67b |
22.48 ± 0.35a |
|
|
La |
34.12 ± 0.43b |
25.63 ± 1.10b |
17.58 ± 0.72a |
18.54 ± 0.43b |
|
Xiangyaxiangzhan |
|
|
CK |
40.59 ± 0.62a |
35.73 ± 1.15a |
13.46 ± 1.15b |
21.01 ± 0.45a |
|
|
La |
31.19 ± 0.53b |
28.08 ± 1.71b |
18.27 ± 1.07a |
17.13 ± 0.84b |
2019 |
Meixiangzhan-2 |
|
|
CK |
41.98 ± 0.84a |
34.51 ± 0.23a |
12.04 ± 0.91b |
21.51 ± 0.39a |
|
|
La |
33.21 ± 1.20b |
24.12 ± 1.57b |
18.89 ± 1.27a |
17.39 ± 0.59b |
|
Xiangyaxiangzhan |
|
|
CK |
43.31 ± 2.67a |
39.16 ± 1.28a |
13.23 ± 1.09b |
20.99 ± 0.28a |
|
|
La |
32.77 ± 1.71b |
25.89 ± 2.54b |
16.40 ± 0.32a |
18.59 ± 0.25b |
- Values (means ± SEs) of each treatment were obtained from three independent replications (n = 3). Different letters indicate significant differences among the treatments (P < 0.05, least significant difference test)